Benefits of pharmaceutical innovation: the case of simvastatin in Canada.

 


Background: The benefits of pharmaceutical innovations are widely diffused; they accrue to the healthcare providers, patients, employers, and manufacturers. We estimate the societal monetary benefits of simvastatin in Canada and its distribution among different beneficiaries overtime.

Publication Type: Journal Articles

Year of Publication: 2012

Topics: Pharmaceuticals

Authors: Thanh Nguyen, Anderson Chuck, Arto Ohinmaa, Philip Jacobs

Journal Title: International Journal of Technology Assessment in Health Care

Volume: 28

Issue: 4

Pages: 390-397